Results for “tour return”

Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment—and genetic changes present from the start may help explain why. Scientists at St. Jude Children's Research Hospital and Seattle Children's Hospital, in collaboration with the Children's Oncology Group, found that mutations in a patient's original tumor can be associated with relapse risk, and that these changes differ by leukemia subtype. The findings, published in Blood, could help researchers better estimate and adjust for relapse risk before treatment begins.

More than a quarter of Americans have exaggerated or made up symptoms to try to get antibiotics from their doctor, either for themselves or for their children, a new study has found. The survey of nearly 1,000 people nationwide uncovered common motivations for misrepresenting symptoms, including feeling very sick or needing to return to work or school.

A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return